Ethyl (E)-oct-2-enoate, 98%, 25g

2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]-, 98%, 250mg

1-(3,5-Di-O-p-chlorobenzoyl-2-deoxy-β-D-ribofuranosyl)-5-ethyluracil, 98%, 100mg

Ethyl 3-(2-chlorophenyl)propanoate, 95.0%, 1g

2,4-Difluorobenzoylacetonitrile, 95.0%, 25g

6-Bromo-5-methoxypyridine-2-carboxylic acid, 97.0%, 100mg

2-Bromoethanol, 95.0%, 500g

N,N-dimethylacetamide, min. 99%, for synthesis, 2.5 l, glass packaging

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridazine, 95.0%, 1g

2-Benzoyl-benzofuran-5-carbaldehyde, 97%, 2.5g

3-(4-ETHOXY-PHENYL)-ISOXAZOL-5-YLAMINE, 95.0%, 50mg

2-Amino-4-cyanopyridine, 97.0%, 100g

Long working distance plan phase 40x/0.65 IOS objective, working distance 2.74 mm